ANDA 84580, held by Barr. Hydrochlorothiazide; Reserpine.
As of Nov 16, 2026, ANDA 84580 (Reserpine And Hydrochlorothiazide), held by Barr, was first approved by FDA on May 30, 1975, with 4 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 30, 1975 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Reserpine And Hydrochlorothiazide25MG;0.125MG ยท tablet;oral | Hydrochlorothiazide; Reserpine | Discontinued |
| Feb 14, 1992 | Supplement 35Labeling | Approved | None posted |
| Jan 22, 1991 | Supplement 34Labeling | Approved | None posted |
| Jun 16, 1989 | Supplement 30Labeling | Approved | None posted |
| Mar 6, 1989 | Supplement 31Labeling | Approved | None posted |
| May 30, 1975 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters